Similar articles

• Elicitation of anti-leukemia cytotoxic responses.

  Bach FH, Sondel PM, Zarling JM. Bach FH, et al. Haematol Blood Transfus. 1979;23:369-76. doi: 10.1007/978-3-642-67057-2_47. Haematol Blood Transfus. 1979. PMID: 161756
• Immune status of leukemia patients.

  Kaneko Y, Miyakoshi H, Aoyagi Y, Aoki T. Kaneko Y, et al. Haematol Blood Transfus. 1985;29:200-3. doi: 10.1007/978-3-642-70385-0_46. Haematol Blood Transfus. 1985. PMID: 3861482 No abstract available.
• Immunologic studies in acute leukemia.

  Santos GW, Mullins GM, Bias WB, Anderson PN, Graziano KD, Klein DL, Burke PJ. Santos GW, et al. Natl Cancer Inst Monogr. 1973 Jun;37:69-75. Natl Cancer Inst Monogr. 1973. PMID: 4268325 No abstract available.
• Effector immune mechanisms in cancer.

  Lotzová E. Lotzová E. Nat Immun Cell Growth Regul. 1985;4(6):293-304. Nat Immun Cell Growth Regul. 1985. PMID: 3911064 Review. No abstract available.
• Immunologic markers in childhood acute lymphocytic leukemia.

  Crist WM, Grossi CE, Pullen DJ, Cooper MD. Crist WM, et al. Semin Oncol. 1985 Jun;12(2):105-21. Semin Oncol. 1985. PMID: 3892693 Review. No abstract available.